Intravenous or intramuscular oxytocin for prevention and intravenous oxytocin for treatment of PPH is the WHO-recommended utero-tonic.4 In cases where oxytocin is not available, misoprostol or injectable uterotonics are recommended as alternative treatments.4 The gene discussed is OXT; the disease is pulmonary arterial hypertension.